Position in LLY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$24,225,822
-$2,507,920 QoQ
Shares Held
26,339
+5.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89.40734272371769.ToString("F0")%
Shared 0.ToString("F0")%
None 10.592657276282319.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GAMCO INVESTORS, INC. ET AL holds $78,759,412 across 8 Drug Manufacturers - General names. LLY ranks #1 (30.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
26,339 | $24,225,822 | |
| 2 | JNJ |
Johnson & Johnson
|
80,414 | $19,656,398 | |
| 3 | PFE |
Pfizer Inc
|
589,634 | $16,556,922 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,769 | $7,791,063 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
87,058 | $5,280,067 | |
| 6 | ABBV |
AbbVie Inc.
|
15,124 | $3,289,318 | |
| 7 | AMGN |
Amgen Inc
|
5,023 | $1,767,342 | |
| 8 | GRFS |
Grifols SA
|
24,000 | $192,480 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,225,822 | 26,339 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $26,733,742 | 24,876 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $19,061,266 | 24,982 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $21,358,342 | 27,399 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $24,835,113 | 30,070 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,895,196 | 33,543 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $30,841,343 | 34,812 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,438,860 | 35,829 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $28,278,068 | 36,349 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $21,355,274 | 36,635 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,425,972 | 30,581 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $14,760,676 | 31,474 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $10,485,642 | 30,533 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,287,993 | 30,855 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $6,174,691 | 19,096 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,956,105 | 18,370 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,416,688 | 18,915 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $5,286,850 | 19,140 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,451,178 | 19,265 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,585,580 | 19,979 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,959,649 | 21,195 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,564,550 | 21,112 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,331,042 | 22,504 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $3,663,184 | 22,312 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,844,208 | 27,712 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||